EUVIMEDEUVIMED entdecken
Open Access

AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia

Niels Vandewalle, Hatice Satilmis, Emma Verheye, Rong Fan, Yanmeng Wang, Timo W M De Groof, Jessica Bridoux, Tessa Kerre, Nathan De Beule, Ann De Becker, Elke De Bruyne, Eline Menu und 4 weitere

Theranostics · 2024

DOI: 10.7150/thno.91456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Niels Vandewalle und 15 weiteren Autor:innen. Beteiligte Einrichtung: Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Vrije Universiteit Brussel, Brussels, Belgium. Hauptthemen laut MEDLINE: Axl Receptor Tyrosine Kinase, Leukemia, Myeloid, Acute, Single-Domain Antibodies. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Axl Receptor Tyrosine KinaseLeukemia, Myeloid, AcuteSingle-Domain AntibodiesAnimalsFemaleHumansMiceAntineoplastic AgentsApoptosisCell Line, TumorCell ProliferationProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesTHP-1 CellsXenograft Model Antitumor Assays

Stichwörter der Autor:innen

AXLacute myeloid leukemianuclear imagingsingle domain antibodiestherapy

Substanzen

Antineoplastic AgentsAXL protein, humanAxl Receptor Tyrosine KinaseProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesSingle-Domain Antibodies

Autor:innen und Institutionen

  • Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Vrije Universiteit Brussel, Brussels, Belgium.
  • Laboratory of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.
  • Brussels Center of Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
  • Laboratory of Molecular Imaging and Therapy (MITH), Vrije Universiteit Brussel, Brussels, Belgium.
  • Department of Hematology, Ghent University Hospital, Ghent, Belgium.
  • Translational Oncology Research Center (TORC), team Hematology and Immunology (HEIM), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Zitieren

APA

Vandewalle, N., Satilmis, H., Verheye, E., Fan, R., Wang, Y., De Groof, T. W. M., Bridoux, J., Kerre, T., De Beule, N., De Becker, A., De Bruyne, E., Menu, E., Vanderkerken, K., Breckpot, K., Devoogdt, N., & De Veirman, K. (2024). AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia. Theranostics. https://doi.org/10.7150/thno.91456

Vancouver

Vandewalle N, Satilmis H, Verheye E, Fan R, Wang Y, De Groof TWM, et al. AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia. Theranostics. 2024. doi:10.7150/thno.91456

BibTeX
@article{Vandewalle2024,
  author = {Vandewalle, Niels and Satilmis, Hatice and Verheye, Emma and Fan, Rong and Wang, Yanmeng and De Groof, Timo W M and Bridoux, Jessica and Kerre, Tessa and De Beule, Nathan and De Becker, Ann and De Bruyne, Elke and Menu, Eline and Vanderkerken, Karin and Breckpot, Karine and Devoogdt, Nick and De Veirman, Kim},
  title = {AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia},
  journal = {Theranostics},
  year = {2024},
  doi = {10.7150/thno.91456}
}
Kostenlos starten →